Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for bladder cancer patients who Can't tolerate chemotherapy

NCT ID NCT05645692

Ongoing Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is testing two new immunotherapy drugs, alone and together, against an existing drug for advanced bladder cancer. It is for patients whose cancer has spread and who are not healthy enough for standard platinum-based chemotherapy. The main goal is to see if the new treatments are safe and if they can help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • *X*CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia

    Santo André, São Paulo, 09060-650, Brazil

  • A.O. Universitaria Ospedale Consorziale Policlinico Di Bari

    Bari, Apulia, 70124, Italy

  • Aarhus Universitetshospital

    Aarhus N, 8200, Denmark

  • Adana Baskent University Medical Faculty

    Adana, 01220, Turkey (Türkiye)

  • Alexandras General Hospital of Athens

    Athens, 115 28, Greece

  • Ankara City Hospital

    Ankara, 06800, Turkey (Türkiye)

  • Asan Medical Center

    Seoul, 05505, South Korea

  • Attikon University General Hospital

    Chaïdári, 124 62, Greece

  • Azienda Ospedaliera S. Maria - Terni

    Terni, Umbria, 05100, Italy

  • Azienda Ospedaliero-Universitaria S.Orsola-Malpighi

    Bologna, Emilia-Romagna, 40138, Italy

  • Barts and the London NHS Trust

    London, E1 2ES, United Kingdom

  • Beijing Cancer Hospital

    Beijing, 100142, China

  • Centre Leon Berard

    Lyon, 69373, France

  • Cleveland Clinic

    Cleveland, Ohio, 44106, United States

  • Gachon University Gil Medical Center

    Incheon, 21565, South Korea

  • Goztepe Prof.Dr. Suleyman Yalcin City Hospital

    Kadiköy, 34722, Turkey (Türkiye)

  • Gustave Roussy

    Villejuif, 94800, France

  • Health Pharma Professional Research

    Mexico City, Mexico CITY (federal District), 03100, Mexico

  • Herlev Hospital

    Herlev, 2730, Denmark

  • Hospital Alemao Oswaldo Cruz

    São Paulo, São Paulo, 01323-903, Brazil

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Clínico San Carlos

    Madrid, 28040, Spain

  • Hospital Universitario Evangelico De Curitiba

    Curitiba, Paraná, 80440-220, Brazil

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Hospital das Clinicas - UFRGS

    Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

  • Hospital de Amor Amazônia

    Porto Velho, Rondônia, 76834-899, Brazil

  • Hospital de Madrid Norte Sanchinarro- Centro Integral Oncologico Clara Campal

    Madrid, 28050, Spain

  • ICON Cancer Care Adelaide

    Kurralta Park, South Australia, 5037, Australia

  • IRCCS Istituto Oncologico Veneto (IOV)

    Padua, Veneto, 35128, Italy

  • IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola

    Meldola, Emilia-Romagna, 47014, Italy

  • Institut Catala d Oncologia Hospital Duran i Reynals

    Barcelona, 08908, Spain

  • Irccs Ospedale San Raffaele

    Milan, Lombardy, 20132, Italy

  • Istituto Nazionale Tumori Irccs Fondazione G. Pascale

    Napoli, Campania, 80131, Italy

  • Izmir Medical Point Hospital

    Izmir, 35101, Turkey (Türkiye)

  • Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie

    Halle, 06120, Germany

  • Lyell McEwin Hospital

    Adelaide, South Australia, 5112, Australia

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Macquarie University Hospital

    Macquarie Park, New South Wales, 2113, Australia

  • Martini-Klinik am UKE GmbH

    Hamburg, 20246, Germany

  • Policlinico Universitario "Agostino Gemelli"

    Rome, Lazio, 00168, Italy

  • Pratia Poznan

    Późna, 60-192, Poland

  • Royal Marsden Hospital (Sutton)

    Sutton, SM2 5PT, United Kingdom

  • Royal Preston Hosptial

    Preston, PR2 9HT, United Kingdom

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, 200025, China

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Seoul National University Bundang Hospital

    Gyeonggi-do, South Korea

  • Seoul National University Hospital

    Seoul, 03080, South Korea

  • Severance Hospital, Yonsei University

    Seoul, 03722, South Korea

  • Sun yat-sen University Cancer Center

    Guangzhou, 510060, China

  • Szpital Grochowski im. dr med. Rafa?a Masztaka Sp. z o.o.

    Warsaw, 04-073, Poland

  • Szpital Uniwersytecki w Krakowie

    Krakow, 31-501, Poland

  • Szpital Wojewódzki im. Miko?aja Kopernika

    Koszalin, 75-581, Poland

  • Theageneio Hospital

    Thessaloniki, 54007, Greece

  • Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi

    Edirne, 22030, Turkey (Türkiye)

  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona

    Barcelona, 08035, Spain

  • West China Hospital - Sichuan University

    Chengdu, 610047, China

Conditions

Explore the condition pages connected to this study.

UROTHELIAL CANCER